Neat News 3444 (added 2025-10-20)
Drug combo against prostate cancer
Public Domain by Henry Vandyke Carter
A study with more than 1000 patients finds that a new drug combo against recurring prostate cancer consisting of enzalutamide (Xtandi) and hormone therapy can reduce death risk by over 40 percent.
related: #prostate_cancer #death_risk #drug